spacer
spacer

PDBsum entry 4hlc

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transferase/transferase inhibitor PDB id
4hlc

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
195 a.a.
Ligands
T05 ×2
Waters ×296
PDB id:
4hlc
Name: Transferase/transferase inhibitor
Title: Sulfonylpiperidines as novel, antibacterial inhibitors of gram- positive thymidylate kinase (tmk): compound 5
Structure: Thymidylate kinase. Chain: a, b. Fragment: tmk. Synonym: dtmp kinase. Engineered: yes
Source: Staphylococcus aureus subsp. Aureus. Organism_taxid: 282458. Strain: mrsa252. Gene: sar0483, tmk. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Resolution:
1.55Å     R-factor:   0.180     R-free:   0.199
Authors: A.Boriack-Sjodin,N.Olivier
Key ref: G.Martínez-Botella et al. (2013). Sulfonylpiperidines as novel, antibacterial inhibitors of Gram-positive thymidylate kinase (TMK). Bioorg Med Chem Lett, 23, 169-173. PubMed id: 23206863
Date:
16-Oct-12     Release date:   31-Oct-12    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q6GJI9  (KTHY_STAAR) -  Thymidylate kinase from Staphylococcus aureus (strain MRSA252)
Seq:
Struc:
205 a.a.
195 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.7.4.9  - dTMP kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: dTMP + ATP = dTDP + ADP
dTMP
+ ATP
= dTDP
+ ADP
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Bioorg Med Chem Lett 23:169-173 (2013)
PubMed id: 23206863  
 
 
Sulfonylpiperidines as novel, antibacterial inhibitors of Gram-positive thymidylate kinase (TMK).
G.Martínez-Botella, J.T.Loch, O.M.Green, S.P.Kawatkar, N.B.Olivier, P.A.Boriack-Sjodin, T.A.Keating.
 
  ABSTRACT  
 
Thymidylate kinase (TMK) is an essential enzyme for DNA synthesis in bacteria, phosphorylating deoxythymidine monophosphate (dTMP) to deoxythymidine diphosphate (dTDP), and thus is a potential new antibacterial drug target. Previously, we have described the first potent and selective inhibitors of Gram-positive TMK, leading to in vivo validation of the target. Here, a structure-guided design approach based on the initial series led to the discovery of novel sulfonylpiperidine inhibitors of TMK. Formation of hydrogen bonds with Arg48 in Staphylococcus aureus TMK was key to obtaining excellent enzyme affinity, as verified by protein crystallography. Replacement of a methylene linker in the series by a sulfonamide was accomplished with retention of binding conformation. Further optimization of logD yielded phenol derivative 11, a potent inhibitor of TMK showing excellent MICs against a broad spectrum of Gram-positive bacteria and >10(5) selectivity versus the human TMK homologue.
 

 

spacer

spacer